Literature DB >> 26834123

Maternal T-Cell Engraftment Interferes With Human Leukocyte Antigen Typing in Severe Combined Immunodeficiency.

Chang Liu1, Brian Duffy2, Jeffrey J Bednarski3, Cecelia Calhoun3, Lindsay Lay4, Barrett Rundblad4, Jacqueline E Payton5, Thalachallour Mohanakumar6.   

Abstract

OBJECTIVES: To report the laboratory investigation of a case of severe combined immunodeficiency (SCID) with maternal T-cell engraftment, focusing on the interference of human leukocyte antigen (HLA) typing by blood chimerism.
METHODS: HLA typing was performed with three different methods, including sequence-specific primer (SSP), sequence-specific oligonucleotide, and Sanger sequencing on peripheral blood leukocytes and buccal cells, from a 3-month-old boy and peripheral blood leukocytes from his parents. Short tandem repeat (STR) testing was performed in parallel.
RESULTS: HLA typing of the patient's peripheral blood leukocytes using the SSP method demonstrated three different alleles for each of the HLA-B and HLA-C loci, with both maternal alleles present at each locus. Typing results from the patient's buccal cells showed a normal pattern of inheritance for paternal and maternal haplotypes. STR enrichment testing of the patient's CD3+ T lymphocytes and CD15+ myeloid cells confirmed maternal T-cell engraftment, while the myeloid cell profile matched the patient's buccal cells.
CONCLUSIONS: Maternal T-cell engraftment may interfere with HLA typing in patients with SCID. Selection of the appropriate typing methods and specimens is critical for accurate HLA typing and immunologic assessment before allogeneic hematopoietic stem cell transplantation. © American Society for Clinical Pathology, 2016. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HLA typing; Maternal T-cell engraftment; Sanger sequencing; Sequence-specific oligonucleotide; Sequence-specific primer; Severe combined immunodeficiency; Short tandem repeat

Mesh:

Substances:

Year:  2016        PMID: 26834123      PMCID: PMC4901308          DOI: 10.1093/ajcp/aqv079

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  18 in total

1.  Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors.

Authors:  Antonio Di Stasi; Denái R Milton; L M Poon; Amir Hamdi; Gabriela Rondon; Julianne Chen; Sai R Pingali; Marina Konopleva; Piyanuch Kongtim; Amin Alousi; Muzaffar H Qazilbash; Sairah Ahmed; Qaiser Bashir; Gheath Al-atrash; Betul Oran; Chitra M Hosing; Partow Kebriaei; Uday Popat; Elizabeth J Shpall; Dean A Lee; Marcos de Lima; Katayoun Rezvani; Issa F Khouri; Richard E Champlin; Stefan O Ciurea
Journal:  Biol Blood Marrow Transplant       Date:  2014-09-28       Impact factor: 5.742

2.  T-B+NK+ severe combined immunodeficiency caused by complete deficiency of the CD3zeta subunit of the T-cell antigen receptor complex.

Authors:  Joseph L Roberts; Jens Peter H Lauritsen; Myriah Cooney; Roberta E Parrott; Elisa O Sajaroff; Chan M Win; Michael D Keller; Jeffery H Carpenter; Juan Carabana; Michael S Krangel; Marcella Sarzotti; Xiao-Ping Zhong; David L Wiest; Rebecca H Buckley
Journal:  Blood       Date:  2006-12-14       Impact factor: 22.113

3.  Feasible outcomes of T cell-replete haploidentical stem cell transplantation with reduced-intensity conditioning in patients with myelodysplastic syndrome.

Authors:  Seung-Hwan Shin; Jung-Ho Kim; Young-Woo Jeon; Jae-Ho Yoon; Seung-Ah Yahng; Sung-Eun Lee; Yun-Suk Choi; Dae-Young Kim; Jung-Hee Lee; Seok Lee; Hee-Je Kim; Chang-Ki Min; Jong-Wook Lee; Kyoo-Hyung Lee; Woo-Sung Min; Yoo-Jin Kim; Je-Hwan Lee
Journal:  Biol Blood Marrow Transplant       Date:  2014-11-20       Impact factor: 5.742

4.  Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients.

Authors:  S M Müller; M Ege; A Pottharst; A S Schulz; K Schwarz; W Friedrich
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

5.  Feasibility of HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for advanced pediatric malignancies.

Authors:  Akihisa Sawada; Mariko Shimizu; Kanako Isaka; Kouhei Higuchi; Azusa Mayumi; Yuri Yoshimoto; Hiroaki Kikuchi; Osamu Kondo; Maho Koyama-Sato; Masahiro Yasui; Keisei Kawa; Masami Inoue
Journal:  Pediatr Hematol Oncol       Date:  2014-10-17       Impact factor: 1.969

Review 6.  Molecular basis of adenosine deaminase deficiency.

Authors:  M L Markert
Journal:  Immunodeficiency       Date:  1994

7.  High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Authors:  Stephanie J Lee; John Klein; Michael Haagenson; Lee Ann Baxter-Lowe; Dennis L Confer; Mary Eapen; Marcelo Fernandez-Vina; Neal Flomenberg; Mary Horowitz; Carolyn K Hurley; Harriet Noreen; Machteld Oudshoorn; Effie Petersdorf; Michelle Setterholm; Stephen Spellman; Daniel Weisdorf; Thomas M Williams; Claudio Anasetti
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

8.  Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation.

Authors:  Joseph L Roberts; Andrea Lengi; Stephanie M Brown; Min Chen; Yong-Jie Zhou; John J O'Shea; Rebecca H Buckley
Journal:  Blood       Date:  2003-11-13       Impact factor: 22.113

9.  Transplantation outcomes for severe combined immunodeficiency, 2000-2009.

Authors:  Sung-Yun Pai; Brent R Logan; Linda M Griffith; Rebecca H Buckley; Roberta E Parrott; Christopher C Dvorak; Neena Kapoor; Imelda C Hanson; Alexandra H Filipovich; Soma Jyonouchi; Kathleen E Sullivan; Trudy N Small; Lauri Burroughs; Suzanne Skoda-Smith; Ann E Haight; Audrey Grizzle; Michael A Pulsipher; Ka Wah Chan; Ramsay L Fuleihan; Elie Haddad; Brett Loechelt; Victor M Aquino; Alfred Gillio; Jeffrey Davis; Alan Knutsen; Angela R Smith; Theodore B Moore; Marlis L Schroeder; Frederick D Goldman; James A Connelly; Matthew H Porteus; Qun Xiang; William T Shearer; Thomas A Fleisher; Donald B Kohn; Jennifer M Puck; Luigi D Notarangelo; Morton J Cowan; Richard J O'Reilly
Journal:  N Engl J Med       Date:  2014-07-31       Impact factor: 91.245

10.  Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas.

Authors:  L Castagna; S Bramanti; S Furst; L Giordano; R Crocchiolo; B Sarina; E Mauro; L Morabito; R Bouabdallah; D Coso; M Balzarotti; F Broussais; J El-Cheikh; C C Stella; E Brusamolino; D Blaise; A Santoro
Journal:  Bone Marrow Transplant       Date:  2014-09-15       Impact factor: 5.483

View more
  2 in total

1.  Novel Hemizygous IL2RG p.(Pro58Ser) Mutation Impairs IL-2 Receptor Complex Expression on Lymphocytes Causing X-Linked Combined Immunodeficiency.

Authors:  Elina A Tuovinen; Juha Grönholm; Tiina Öhman; Sakari Pöysti; Raine Toivonen; Anna Kreutzman; Kaarina Heiskanen; Luca Trotta; Sanna Toiviainen-Salo; John M Routes; James Verbsky; Satu Mustjoki; Janna Saarela; Juha Kere; Markku Varjosalo; Arno Hänninen; Mikko R J Seppänen
Journal:  J Clin Immunol       Date:  2020-02-19       Impact factor: 8.317

2.  Vertically transferred maternal immune cells promote neonatal immunity against early life infections.

Authors:  Ina Annelies Stelzer; Christopher Urbschat; Steven Schepanski; Kristin Thiele; Ioanna Triviai; Agnes Wieczorek; Malik Alawi; Denise Ohnezeit; Julian Kottlau; Jiabin Huang; Nicole Fischer; Hans-Willi Mittrücker; Maria Emilia Solano; Boris Fehse; Anke Diemert; Felix R Stahl; Petra Clara Arck
Journal:  Nat Commun       Date:  2021-08-04       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.